Fig. 9
Galangin 3-methyl ether (G3-ME) alleviates pathological cardiac hypertrophy both in vivo and in vitro by targeting HDAC2 and subsequently deactivating the PI3K-AKT signaling pathway.
Fig. 9 | Acta Pharmacologica Sinica
Galangin 3-methyl ether (G3-ME) alleviates pathological cardiac hypertrophy both in vivo and in vitro by targeting HDAC2 and subsequently deactivating the PI3K-AKT signaling pathway.
